Invivyd (IVVD) Amortizatization of Intangibles (2021 - 2023)
Invivyd (IVVD) posted Amortizatization of Intangibles of -$5.1 million for Q4 2023, down 403.43% on a QoQ basis from $1.7 million in Q3 2023, and down 342.74% year-over-year from $2.1 million in Q4 2022.
Invivyd (IVVD) Amortizatization of Intangibles (2021 - 2023) Analysis & Trends
Invivyd's Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at -$5.1 million for Q4 2023.
- Quarterly Amortizatization of Intangibles fell 342.74% year-over-year to -$5.1 million in Q4 2023, while the trailing twelve-month figure through Sep 2024 was -$5.1 million (down 161.33% YoY) and the FY2023 annual result came in at $1.1 million, down 44.54% from the prior year.
- Amortizatization of Intangibles was -$5.1 million for Q4 2023 at Invivyd, down from $1.7 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.5 million in Q1 2023 and bottomed at -$5.1 million in Q4 2023.
- A 3-year average of $190555.6 and a median of $577000.0 in 2021 frame the typical range for Amortizatization of Intangibles.
- Peak annual rise in Amortizatization of Intangibles reached 1558.82% in 2023, while the deepest fall reached 342.74% in 2023.
- Invivyd's Amortizatization of Intangibles stood at -$2.0 million in 2021, then jumped by 205.38% to $2.1 million in 2022, then slumped by 342.74% to -$5.1 million in 2023.
- Business Quant data shows IVVD's Amortizatization of Intangibles at -$5.1 million in Q4 2023, $1.7 million in Q3 2023, and $2.0 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -5.13 Mn |
| Dec 31, 2023 | -5.13 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | 2.02 Mn |
| Jun 30, 2023 | 2.02 Mn |
| Mar 31, 2023 | 2.54 Mn |
| Mar 31, 2023 | 2.54 Mn |
| Dec 31, 2022 | 2.12 Mn |
| Dec 31, 2022 | 2.12 Mn |
| Sep 30, 2022 | 102,000.00 |
| Sep 30, 2022 | 102,000.00 |
| Mar 31, 2022 | -194,000.00 |
| Mar 31, 2022 | -194,000.00 |
| Dec 31, 2021 | -2.01 Mn |
| Dec 31, 2021 | -2.01 Mn |
| Sep 30, 2021 | 577,000.00 |
| Sep 30, 2021 | 577,000.00 |